Barriers against and strategies for malaria control during the COVID-19 pandemic in low- and middle-income countries: a systematic review

Abstract

Background The COVID-19 pandemic has disrupted malaria control activities globally. Notably, high levels of excess malaria morbidity and mortality in low- and middle-income countries (LMICs) were reported. Although it is crucial to systematically understand the main causes of the disruption to malaria control and synthesize strategies to prepare for future pandemics, such studies are scarce. Therefore, this study aims to better identify barriers against and strategies for malaria control. Methods Following the PRISMA guidelines and through searches of electronic databases and Google Scholar, a systematic literature review was conducted to identify studies pertaining to malaria control published between January 2020 and December 2021. Only studies that discussed reported barriers and/or strategies related to malaria were included for the review. The Mixed Methods Quality Appraisal Tool (MMAT) and the Authority, Accuracy, Coverage, Objectivity, Date and Significance (AACODS) checklist were used for quality appraisal. Key information such as literature type, study design, setting and population, interventions, outcomes, barriers, and strategies were extracted. With an existing framework of four dimensions (accessibility, affordability, availability, and acceptability) further subdivided by the supply and demand sides, this study synthesized information on barriers and strategies related to malaria control and further categorized the strategies based on the time frame. Results From the 30 selected studies, 27 barriers and 39 strategies were identified. The lockdown measures, which mainly threatened geographic accessibility and availability of malaria control services, were identified to be the main barrier hindering effective mobilization of community health workers and resources. Among the identified strategies, clear risk communication strategies would alleviate psychosocial barriers, which challenged acceptability. Some strategies that cross-cut points across all four dimensions would, require systems-level integration to enhance availability and affordability of malaria control. The strategies were distinguished between short-term, for instant response, and mid to long-term for future readiness. Conclusions The pandemic resulted in complex barriers to malaria control, particularly imposing a double burden on LMICs. Identifying strategies to overcome said barriers provides useful insights in the decision-making processes for the current and future pandemic. Cross-cutting strategies that integrate all dimensions need to be considered. Health system strengthening and resilience strategy appropriate for country-specific context is fundamental.

Identifying childhood malaria hotspots and risk factors in a Nigerian city using geostatistical modelling approach

“…Coupled with the recent slow progress in malaria reduction in SSA, the recent global pandemic—coronavirus disease (COVID-19)—has further contributed to the interruption of malaria control undertakings in malaria endemic regions of the world. Park et al 7 reported the high levels of surfeit malaria morbidity and mortality in Low and Middle Income Countries (LMICs), which could be attributed to poor community engagement and limited malaria tests. For example, the work of Ilesanmi, Afolabi and Iyiola 8 identifies limited acquisition of malaria tests to healthcare providers as a barrier against visiting health facilities.…”

A Comparative Study of Genetic Diversity and Multiplicity of Infection in Uncomplicated Plasmodium falciparum Infections in Selected Regions of Pre-Elimination and High Transmission Settings Using MSP1 and MSP2 Genes

“…However, the World Health Organization (WHO) recently reported 247 million malaria cases in 2021, as against 245 million cases reported in 2020 and 231 million cases in 2019. This marked increase might be partly due to the COVID-19 pandemic, which caused interruptions of malaria control interventions in many malaria-endemic countries [ 3 ], as funds for malaria control were diverted to curtail the effects of the pandemic in low and middle income countries [ 4 , 5 ]. WHO estimates indicate that African regions have the largest malaria burden in the world, accounting for 95% of cases and 96% of deaths from the disease, with children under the age of five accounting for 80% of these deaths [ 3 ].…”

Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action

“…[2] Unfortunately, the COVID-19 pandem-ic has disrupted aid campaigns and control efforts, exacerbating the situation. [3,4] As a result, new programs have been launched to reduce malaria incidence and mortality by 2030. [5] Preventive therapies may include vaccines such as RTS,S/AS01 or schizonticidal agents such as Malarone (atovaquone + proguanil), chloroquine (Figure 1), a broad-spectrum antimalarial agent whose efficacy is dramatically decreasing in the last years due to the rise of resistant phenotypes, and artemisinins (Figure 1), depending on the specific species of the infecting protozoa.…”

“…In 2021 alone, World Health Organization (WHO) estimated that there were more than 200 million cases of malaria worldwide, resulting in around 600,000 deaths [2] . Unfortunately, the COVID‐19 pandemic has disrupted aid campaigns and control efforts, exacerbating the situation [3,4] . As a result, new programs have been launched to reduce malaria incidence and mortality by 2030 [5] .…”